Filed: 2/13/2023ACC: 0001095449-23-000030
📋 What this filing means
TAMARACK ADVISERS, LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $194.19M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$194.19M
Total AUM (reported)
15.91M
Total Shares
Allocation by class
EQUITY$138.28M71.2%
LISTED OPTION$55.86M28.8%
WARRANT$50.2K0.0%
Portfolio Concentration
Top 3$63.41M32.7%
4–10$58.61M30.2%
11–25$59.67M30.7%
Rest$12.50M6.4%
Top 3 weight
32.7%
Top 10 weight
62.8%
Voting Authority Distribution
Total shares with voting rights: 15.91M
Sole
Full voting authority
15.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
QQQ Jan3 270.0 P
SOLEShares150K
TypeSH
Market value$39.94M
20.57%
Sole
150K
Shared
0.00
None
0.00
VERADIGM ORD
SOLEShares715K
TypeSH
Market value$12.61M
6.49%
Sole
715K
Shared
0.00
None
0.00
VIATRIS ORD
SOLEShares975K
TypeSH
Market value$10.85M
5.59%
Sole
975K
Shared
0.00
None
0.00
SPY Jan3 380.0 P
SOLEShares25K
TypeSH
Market value$9.56M
4.92%
Sole
25K
Shared
0.00
None
0.00
PHREESIA ORD
SOLEShares285K
TypeSH
Market value$9.22M
4.75%
Sole
285K
Shared
0.00
None
0.00
CERUS ORD
SOLEShares2.50M
TypeSH
Market value$9.13M
4.70%
Sole
2.50M
Shared
0.00
None
0.00
COLLEGIUM PHARMACEUTICAL ORD
SOLEShares387K
TypeSH
Market value$8.98M
4.62%
Sole
387K
Shared
0.00
None
0.00
STREAMLINE HEALTH SOLUTIONS ORD
SOLEShares4.93M
TypeSH
Market value$7.79M
4.01%
Sole
4.93M
Shared
0.00
None
0.00
ALKERMES ORD
SOLEShares275K
TypeSH
Market value$7.19M
3.70%
Sole
275K
Shared
0.00
None
0.00
ANGIODYNAMICS ORD
SOLEShares490K
TypeSH
Market value$6.75M
3.47%
Sole
490K
Shared
0.00
None
0.00
BDX Jan3 260.0 P
SOLEShares25K
TypeSH
Market value$6.36M
3.27%
Sole
25K
Shared
0.00
None
0.00
BIOGEN ORD
SOLEShares20K
TypeSH
Market value$5.54M
2.85%
Sole
20K
Shared
0.00
None
0.00
ASCENDIS PHARMA ADR REP ORD
SOLEShares45K
TypeSH
Market value$5.50M
2.83%
Sole
45K
Shared
0.00
None
0.00
LANTHEUS HOLDINGS ORD
SOLEShares105K
TypeSH
Market value$5.35M
2.76%
Sole
105K
Shared
0.00
None
0.00
TENET HEALTHCARE ORD
SOLEShares95K
TypeSH
Market value$4.64M
2.39%
Sole
95K
Shared
0.00
None
0.00
SI BONE ORD
SOLEShares330K
TypeSH
Market value$4.49M
2.31%
Sole
330K
Shared
0.00
None
0.00
PACIRA BIOSCIENCES ORD
SOLEShares100K
TypeSH
Market value$3.86M
1.99%
Sole
100K
Shared
0.00
None
0.00
NEOGEN ORD
SOLEShares250K
TypeSH
Market value$3.81M
1.96%
Sole
250K
Shared
0.00
None
0.00
RIGEL PHARMACEUTICALS ORD
SOLEShares2.30M
TypeSH
Market value$3.45M
1.78%
Sole
2.30M
Shared
0.00
None
0.00
INMODE ORD
SOLEShares90K
TypeSH
Market value$3.21M
1.65%
Sole
90K
Shared
0.00
None
0.00
TACTILE SYSTEMS TECHNOLOGY ORD
SOLEShares255K
TypeSH
Market value$2.93M
1.51%
Sole
255K
Shared
0.00
None
0.00
MERCK & CO ORD
SOLEShares25K
TypeSH
Market value$2.77M
1.43%
Sole
25K
Shared
0.00
None
0.00
TURNING POINT BRANDS ORD
SOLEShares125K
TypeSH
Market value$2.70M
1.39%
Sole
125K
Shared
0.00
None
0.00
DOCGO ORD
SOLEShares375K
TypeSH
Market value$2.65M
1.37%
Sole
375K
Shared
0.00
None
0.00
SANOFI ADR REP 1 1/2 ORD
SOLEShares50K
TypeSH
Market value$2.42M
1.25%
Sole
50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
QQQ Jan3 270.0 PSOLE | Listed Option | 150K | SH | $39.94M 20.57% | 150K | 0.00 | 0.00 |
VERADIGM ORDSOLE | Equity | 715K | SH | $12.61M 6.49% | 715K | 0.00 | 0.00 |
VIATRIS ORDSOLE | Equity | 975K | SH | $10.85M 5.59% | 975K | 0.00 | 0.00 |
SPY Jan3 380.0 PSOLE | Listed Option | 25K | SH | $9.56M 4.92% | 25K | 0.00 | 0.00 |
PHREESIA ORDSOLE | Equity | 285K | SH | $9.22M 4.75% | 285K | 0.00 | 0.00 |
CERUS ORDSOLE | Equity | 2.50M | SH | $9.13M 4.70% | 2.50M | 0.00 | 0.00 |
COLLEGIUM PHARMACEUTICAL ORDSOLE | Equity | 387K | SH | $8.98M 4.62% | 387K | 0.00 | 0.00 |
STREAMLINE HEALTH SOLUTIONS ORDSOLE | Equity | 4.93M | SH | $7.79M 4.01% | 4.93M | 0.00 | 0.00 |
ALKERMES ORDSOLE | Equity | 275K | SH | $7.19M 3.70% | 275K | 0.00 | 0.00 |
ANGIODYNAMICS ORDSOLE | Equity | 490K | SH | $6.75M 3.47% | 490K | 0.00 | 0.00 |
BDX Jan3 260.0 PSOLE | Listed Option | 25K | SH | $6.36M 3.27% | 25K | 0.00 | 0.00 |
BIOGEN ORDSOLE | Equity | 20K | SH | $5.54M 2.85% | 20K | 0.00 | 0.00 |
ASCENDIS PHARMA ADR REP ORDSOLE | Equity | 45K | SH | $5.50M 2.83% | 45K | 0.00 | 0.00 |
LANTHEUS HOLDINGS ORDSOLE | Equity | 105K | SH | $5.35M 2.76% | 105K | 0.00 | 0.00 |
TENET HEALTHCARE ORDSOLE | Equity | 95K | SH | $4.64M 2.39% | 95K | 0.00 | 0.00 |
SI BONE ORDSOLE | Equity | 330K | SH | $4.49M 2.31% | 330K | 0.00 | 0.00 |
PACIRA BIOSCIENCES ORDSOLE | Equity | 100K | SH | $3.86M 1.99% | 100K | 0.00 | 0.00 |
NEOGEN ORDSOLE | Equity | 250K | SH | $3.81M 1.96% | 250K | 0.00 | 0.00 |
RIGEL PHARMACEUTICALS ORDSOLE | Equity | 2.30M | SH | $3.45M 1.78% | 2.30M | 0.00 | 0.00 |
INMODE ORDSOLE | Equity | 90K | SH | $3.21M 1.65% | 90K | 0.00 | 0.00 |
TACTILE SYSTEMS TECHNOLOGY ORDSOLE | Equity | 255K | SH | $2.93M 1.51% | 255K | 0.00 | 0.00 |
MERCK & CO ORDSOLE | Equity | 25K | SH | $2.77M 1.43% | 25K | 0.00 | 0.00 |
TURNING POINT BRANDS ORDSOLE | Equity | 125K | SH | $2.70M 1.39% | 125K | 0.00 | 0.00 |
DOCGO ORDSOLE | Equity | 375K | SH | $2.65M 1.37% | 375K | 0.00 | 0.00 |
SANOFI ADR REP 1 1/2 ORDSOLE | Equity | 50K | SH | $2.42M 1.25% | 50K | 0.00 | 0.00 |
Page 1 of 2